Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Relationship of Neighborhood Greenness to Heart Disease in 249 405 US Medicare Beneficiaries.

Wang K, Lombard J, Rundek T, Dong C, Gutierrez CM, Byrne MM, Toro M, Nardi MI, Kardys J, Yi L, Szapocznik J, Brown SC.

J Am Heart Assoc. 2019 Mar 19;8(6):e010258. doi: 10.1161/JAHA.118.010258.

2.

Development of a Plain Language Decision Support Tool for Cancer Clinical Trials: Blending Health Literacy, Academic Research, and Minority Patient Perspectives.

Langford AT, Hawley ST, Stableford S, Studts JL, Byrne MM.

J Cancer Educ. 2019 Feb 9. doi: 10.1007/s13187-019-1482-5. [Epub ahead of print]

PMID:
30739270
3.

Capecitabine for the treatment of pancreatic cancer.

Siddiqui NS, Godara A, Byrne MM, Saif MW.

Expert Opin Pharmacother. 2019 Mar;20(4):399-409. doi: 10.1080/14656566.2018.1560422. Epub 2019 Jan 16. Review.

PMID:
30649964
4.

Lung cancer screening in a community setting: Characteristics, motivations, and attitudes of individuals being screened.

Byrne MM, Lillie SE, Studts JL.

Health Psychol Open. 2019 Jan 3;6(1):2055102918819163. doi: 10.1177/2055102918819163. eCollection 2019 Jan-Jun.

5.

An evolving spectrum of diabetes in a woman with GCK-MODY.

Garrahy A, Mijares Zamuner MB, Byrne MM.

Endocrinol Diabetes Metab Case Rep. 2019 Jan 3;2019. pii: EDM180145. doi: 10.1530/EDM-18-0145. [Epub ahead of print]

6.

The safety of lanreotide for neuroendocrine tumor.

Godara A, Siddiqui NS, Byrne MM, Saif MW.

Expert Opin Drug Saf. 2019 Jan;18(1):1-10. doi: 10.1080/14740338.2019.1559294. Epub 2018 Dec 24.

PMID:
30582380
7.

National estimates and correlates of secondhand smoke exposure in US cancer survivors.

Asfar T, Arheart KL, Koru-Sengul T, Byrne MM, Dietz NA, Chen CJ, Lee DJ.

J Cancer Surviv. 2017 Aug;11(4):469-476. doi: 10.1007/s11764-017-0605-4. Epub 2017 Feb 21.

PMID:
28224453
8.

Acute presentation of a giant intrathyroidal parathyroid adenoma: a case report.

Rutledge S, Harrison M, O'Connell M, O'Dwyer T, Byrne MM.

J Med Case Rep. 2016 Oct 19;10(1):286.

9.

CNE Certification Drive and Exam Results.

Byrne MM, Welch S.

Nurs Educ Perspect. 2016 Jul/Aug;37(4):221-223.

PMID:
27740581
10.

Fertility Desires among Women Living with HIV.

Jones DL, Cook R, Potter JE, Miron-Shatz T, Chakhtoura N, Spence A, Byrne MM.

PLoS One. 2016 Sep 9;11(9):e0160190. doi: 10.1371/journal.pone.0160190. eCollection 2016.

11.

Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood.

Bacon S, Kyithar MP, Condron EM, Vizzard N, Burke M, Byrne MM.

Acta Diabetol. 2016 Dec;53(6):965-972. doi: 10.1007/s00592-016-0890-9. Epub 2016 Aug 23.

PMID:
27552834
12.

Decision Aids Can Support Cancer Clinical Trials Decisions: Results of a Randomized Trial.

Politi MC, Kuzemchak MD, Kaphingst KA, Perkins H, Liu J, Byrne MM.

Oncologist. 2016 Dec;21(12):1461-1470. Epub 2016 Aug 10.

13.

Combining Community-Based Participatory Research (CBPR) with a Random-Sample Survey to Assess Smoking Prevalence in an Under-Served Community.

Messiah A, Dietz NA, Byrne MM, Hooper MW, Fernandez CA, Baker EA, Stevens M, Ocasio M, Sherman RL, Parker DF, Lee DJ.

J Natl Med Assoc. 2015 Jun;107(2):97-101. doi: 10.1016/S0027-9684(15)30030-4. Epub 2015 Dec 2.

PMID:
27269496
14.

Neighborhood Greenness and Chronic Health Conditions in Medicare Beneficiaries.

Brown SC, Lombard J, Wang K, Byrne MM, Toro M, Plater-Zyberk E, Feaster DJ, Kardys J, Nardi MI, Perez-Gomez G, Pantin HM, Szapocznik J.

Am J Prev Med. 2016 Jul;51(1):78-89. doi: 10.1016/j.amepre.2016.02.008. Epub 2016 Apr 6.

PMID:
27061891
15.

Predictors of Surgery Types after Neoadjuvant Therapy for Advanced Stage Breast Cancer: Analysis from Florida Population-Based Cancer Registry (1996-2009).

Al-Azhri J, Koru-Sengul T, Miao F, Saclarides C, Byrne MM, Avisar E.

Breast Cancer (Auckl). 2015 Dec 13;9:99-108. doi: 10.4137/BCBCR.S31503. eCollection 2015.

16.

Detecting Allelic Expression Imbalance at Candidate Genes Using 5' Exonuclease Genotyping Technology.

Gahan JM, Byrne MM, Hill M, Quinn EM, Murphy RT, Anney RJ, Ryan AW.

Methods Mol Biol. 2015;1326:93-103. doi: 10.1007/978-1-4939-2839-2_10.

PMID:
26498616
17.

Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.

Bacon S, Kyithar MP, Rizvi SR, Donnelly E, McCarthy A, Burke M, Colclough K, Ellard S, Byrne MM.

Diabet Med. 2016 Jul;33(7):976-84. doi: 10.1111/dme.12992. Epub 2015 Nov 17.

PMID:
26479152
18.

Smoking and survival in male breast cancer patients.

Padron-Monedero A, Koru-Sengul T, Tannenbaum SL, Miao F, Hansra D, Lee DJ, Byrne MM.

Breast Cancer Res Treat. 2015 Oct;153(3):679-87. doi: 10.1007/s10549-015-3582-1. Epub 2015 Sep 26.

PMID:
26409835
19.

MicroRNA-224 is Readily Detectable in Urine of Individuals with Diabetes Mellitus and is a Potential Indicator of Beta-Cell Demise.

Bacon S, Engelbrecht B, Schmid J, Pfeiffer S, Gallagher R, McCarthy A, Burke M, Concannon C, Prehn JH, Byrne MM.

Genes (Basel). 2015 Jun 23;6(2):399-416. doi: 10.3390/genes6020399.

20.

The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young.

Bacon S, Schmid J, McCarthy A, Edwards J, Fleming A, Kinsley B, Firth R, Byrne B, Gavin C, Byrne MM.

Am J Obstet Gynecol. 2015 Aug;213(2):236.e1-7. doi: 10.1016/j.ajog.2015.04.037. Epub 2015 Apr 30.

PMID:
25935773
21.

Disparities in Overall Survival for Male Breast Cancer Patients in the State of Florida (1996-2007).

O'Brien B, Koru-Sengul T, Miao F, Saclarides C, Tannenbaum SL, Alghamdi H, Lee DJ, Franceschi D, Byrne MM, Avisar E.

Clin Breast Cancer. 2015 Aug;15(4):e177-87. doi: 10.1016/j.clbc.2014.12.010. Epub 2015 Jan 7.

PMID:
25726509
22.

Smoking and survival in female breast cancer patients.

Padron-Monedero A, Tannenbaum SL, Koru-Sengul T, Miao F, Hansra D, Lee DJ, Byrne MM.

Breast Cancer Res Treat. 2015 Apr;150(2):395-403. doi: 10.1007/s10549-015-3317-3. Epub 2015 Feb 28.

PMID:
25724306
23.

Health Information Seeking and Cancer Screening Adherence Rates.

Shneyderman Y, Rutten LJ, Arheart KL, Byrne MM, Kornfeld J, Schwartz SJ.

J Cancer Educ. 2016 Mar;31(1):75-83. doi: 10.1007/s13187-015-0791-6.

PMID:
25619195
24.

Factors associated with contralateral preventive mastectomy.

Yakoub D, Avisar E, Koru-Sengul T, Miao F, Tannenbaum SL, Byrne MM, Moffat F, Livingstone A, Franceschi D.

Breast Cancer (Dove Med Press). 2015 Jan 7;7:1-8. doi: 10.2147/BCTT.S72737. eCollection 2015.

25.

BH3-Only protein bmf is required for the maintenance of glucose homeostasis in an in vivo model of HNF1α-MODY diabetes.

Pfeiffer S, Halang L, Düssmann H, Byrne MM, Prehn J.

Cell Death Discov. 2015 Oct 5;1:15041. doi: 10.1038/cddiscovery.2015.41. eCollection 2015.

26.

Epigenetic modulation in the treatment of atherosclerotic disease.

Byrne MM, Murphy RT, Ryan AW.

Front Genet. 2014 Oct 28;5:364. doi: 10.3389/fgene.2014.00364. eCollection 2014. Review.

27.

Cost of a community-based diabetic retinopathy screening program.

Byrne MM, Parker DF, Tannenbaum SL, Ocasio MA, Lam BL, Zimmer-Galler I, Lee DJ.

Diabetes Care. 2014 Nov;37(11):e236-7. doi: 10.2337/dc14-0834. No abstract available.

PMID:
25342836
28.

Racial and ethnic disparities in the diagnosis of breast cancer: changes in presenting stage in minority populations in Florida during 1981-2009.

Dosch AR, Koru-Sengul T, Miao F, Tannenbaum SL, Byrne MM, Wright JL.

Breast Cancer Res Treat. 2014 Nov;148(2):379-87. doi: 10.1007/s10549-014-3158-5. Epub 2014 Oct 10.

PMID:
25301087
29.

Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.

Tannenbaum SL, Koru-Sengul T, Zhao W, Miao F, Byrne MM.

Cancer J. 2014 Jul-Aug;20(4):237-45. doi: 10.1097/PPO.0000000000000058.

PMID:
25098282
30.

Rationale and design of the research project of the South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS): study protocol for a randomized controlled trial.

Carrasquillo O, McCann S, Amofah A, Pierre L, Rodriguez B, Alonzo Y, Ilangovan K, Gonzalez M, Trevil D, Byrne MM, Koru-Sengul T, Kobetz E.

Trials. 2014 Jul 23;15:299. doi: 10.1186/1745-6215-15-299.

31.

Native American race, use of the Indian Health Service, and breast and lung cancer survival in Florida, 1996-2007.

Lee DJ, Tannenbaum SL, Koru-Sengul T, Miao F, Zhao W, Byrne MM.

Prev Chronic Dis. 2014 Mar 6;11:E35. doi: 10.5888/pcd11.130162.

32.

Florida Red Tide Knowledge and Risk Perception: Is there a need for tailored messaging?

Kirkpatrick B, Kohler K, Byrne MM, Studts J.

Harmful Algae. 2014 Feb 1;32:27-32.

33.

Creating peer groups for assessing and comparing nursing home performance.

Byrne MM, Daw C, Pietz K, Reis B, Petersen LA.

Am J Manag Care. 2013 Nov;19(11):933-9.

34.

Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy.

Neff KJ, Forde R, Gavin C, Byrne MM, Firth RG, Daly S, McAuliffe FM, Foley M, Coffey M, Coulter-Smith S, Kinsley BT.

Ir J Med Sci. 2014 Sep;183(3):397-403. doi: 10.1007/s11845-013-1027-6. Epub 2013 Oct 22.

PMID:
24142539
35.

Circulating CD36 is reduced in HNF1A-MODY carriers.

Bacon S, Kyithar MP, Schmid J, Costa Pozza A, Handberg A, Byrne MM.

PLoS One. 2013 Sep 12;8(9):e74577. doi: 10.1371/journal.pone.0074577. eCollection 2013.

36.

Participation in cancer clinical trials: why are patients not participating?

Byrne MM, Tannenbaum SL, Glück S, Hurley J, Antoni M.

Med Decis Making. 2014 Jan;34(1):116-26. doi: 10.1177/0272989X13497264. Epub 2013 Jul 29.

PMID:
23897588
37.

Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.

Kyithar MP, Bonner C, Bacon S, Kilbride SM, Schmid J, Graf R, Prehn JH, Byrne MM.

J Transl Med. 2013 Jun 26;11:156. doi: 10.1186/1479-5876-11-156.

38.

Disparities in survival after female breast cancer diagnosis: a population-based study.

Tannenbaum SL, Koru-Sengul T, Miao F, Byrne MM.

Cancer Causes Control. 2013 Sep;24(9):1705-15. doi: 10.1007/s10552-013-0246-5. Epub 2013 Jun 18.

PMID:
23775026
39.

Identification of circulating microRNAs in HNF1A-MODY carriers.

Bonner C, Nyhan KC, Bacon S, Kyithar MP, Schmid J, Concannon CG, Bray IM, Stallings RL, Prehn JH, Byrne MM.

Diabetologia. 2013 Aug;56(8):1743-51. doi: 10.1007/s00125-013-2939-4. Epub 2013 May 15.

PMID:
23674172
40.

HPV knowledge and vaccine acceptability among Hispanic fathers.

Kornfeld J, Byrne MM, Vanderpool R, Shin S, Kobetz E.

J Prim Prev. 2013 Apr;34(1-2):59-69. doi: 10.1007/s10935-013-0297-0.

41.

Marital status and its effect on lung cancer survival.

Tannenbaum SL, Zhao W, Koru-Sengul T, Miao F, Lee D, Byrne MM.

Springerplus. 2013 Oct 3;2:504. doi: 10.1186/2193-1801-2-504. eCollection 2013.

42.

Developing an urban community-campus partnership: lessons learned in infrastructure development and communication.

Parker DF, Dietz NA, Hooper MW, Byrne MM, Fernandez CA, Baker EA, Stevens MS, Messiah A, Lee DJ, Kobetz EN.

Prog Community Health Partnersh. 2012 Winter;6(4):435-41. doi: 10.1353/cpr.2012.0058.

PMID:
23221288
43.

Primary hyperparathyroidism in a patient with familial hypocalciuric hypercalcaemia due to a novel mutation in the calcium-sensing receptor gene.

Egan AM, Ryan J, Aziz MA, O'Dwyer TP, Byrne MM.

J Bone Miner Metab. 2013 Jul;31(4):477-80. doi: 10.1007/s00774-012-0399-4. Epub 2012 Oct 19.

PMID:
23081733
44.

The impact of certification on certified perioperative nurses: a qualitative descriptive survey.

Schroeter K, Byrne MM, Klink KA, Beier M, McAndrew NS.

ORNAC J. 2012 Sep;30(3):34-8, 40-1, 44-6.

PMID:
23066598
45.
46.

Discussions of cancer clinical trials with the National Cancer Institute's Cancer Information Service.

Byrne MM, Kornfeld J, Vanderpool R, Belanger M.

J Health Commun. 2012;17(3):319-37. doi: 10.1080/10810730.2011.626500. Epub 2011 Dec 12.

47.

Development and preliminary results of the Financial Incentive Coercion Assessment questionnaire.

Byrne MM, Croft JR, French MT, Dugosh KL, Festinger DS.

J Subst Abuse Treat. 2012 Jul;43(1):86-93. doi: 10.1016/j.jsat.2011.10.002. Epub 2011 Nov 23.

48.

Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.

Farrelly AM, Kilbride SM, Bonner C, Prehn JH, Byrne MM.

Apoptosis. 2011 Nov;16(11):1128-37. doi: 10.1007/s10495-011-0641-x.

PMID:
21874357
49.

Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?

Koniaris LG, Levi DM, Pedroso FE, Franceschi D, Tzakis AG, Santamaria-Barria JA, Tang J, Anderson M, Misra S, Solomon NL, Jin X, DiPasco PJ, Byrne MM, Zimmers TA.

Ann Surg. 2011 Sep;254(3):527-37; discussion 537-8. doi: 10.1097/SLA.0b013e31822ca66f.

50.

Factors related to menopausal symptom management decisions.

Carpenter JS, Byrne MM, Studts JL.

Maturitas. 2011 Sep;70(1):10-5. doi: 10.1016/j.maturitas.2011.06.002. Epub 2011 Jun 30. Review.

PMID:
21723054

Supplemental Content

Loading ...
Support Center